Additionally, we detected a significant elevation in markers of necroptosis in the cochlea, alongside a significant decrease in the ferroptosis marker GPX4 and an increase in the expression of 4-HNE after the combined treatment of MD and LPS. This evidence concerns the gene GPX4 and Menkes disease.